Cardiovascular Outcomes of Sitagliptin in Type 2 Diabetic Patients with Acute Myocardial Infarction, a Population-Based Cohort Study in Taiwan

BACKGROUND: The cardiovascular safety and efficacy of sitagliptin, a dipeptidyl peptidase 4 (DPP-4) inhibitor, in type 2 diabetic patients after acute myocardial infarction (AMI) has so far remained uncertain. METHODS: We analyzed data from the National Health Insurance Research Database (NHIRD), a...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:PLoS One
Huvudupphovsmän: Wang, Szu-Heng, Chen, Dong-Yi, Lin, Yu-Sheng, Mao, Chun-Tai, Tsai, Ming-Lung, Hsieh, Ming-Jer, Chou, Chung-Chuan, Wen, Ming-Shien, Wang, Chun-Chieh, Hsieh, I-Chang, Hung, Kuo-Chun, Chen, Tien-Hsing
Materialtyp: Artigo
Språk:Inglês
Publicerad: Public Library of Science 2015
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4482692/
https://ncbi.nlm.nih.gov/pubmed/26115092
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0131122
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk